Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond

Future Oncol. 2015;11(16):2263-6. doi: 10.2217/fon.15.161.
No abstract available

Keywords: HCC; RAS/RAF/MEK/ERK pathway; multikinase inhibitors; sorafenib.

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / pathology*
  • Clinical Trials, Phase III as Topic
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / pathology*
  • Neoplasm Staging
  • Niacinamide / analogs & derivatives*
  • Niacinamide / therapeutic use
  • Phenylurea Compounds / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Sorafenib
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Niacinamide
  • Sorafenib